King Luther Capital Management Corp cut its position in shares of Healthequity Inc (NASDAQ:HQY) by 4.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 72,165 shares of the company’s stock after selling 3,045 shares during the period. King Luther Capital Management Corp owned approximately 0.12% of Healthequity worth $6,813,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Invictus RG raised its stake in shares of Healthequity by 153.6% during the 3rd quarter. Invictus RG now owns 8,337 shares of the company’s stock worth $787,000 after acquiring an additional 5,050 shares in the last quarter. Renaissance Technologies LLC grew its position in Healthequity by 1,916.7% during the 3rd quarter. Renaissance Technologies LLC now owns 157,300 shares of the company’s stock worth $14,851,000 after purchasing an additional 149,500 shares during the last quarter. Riverhead Capital Management LLC grew its position in Healthequity by 24.3% during the 3rd quarter. Riverhead Capital Management LLC now owns 23,400 shares of the company’s stock worth $2,209,000 after purchasing an additional 4,571 shares during the last quarter. Mutual of America Capital Management LLC grew its position in Healthequity by 23,682.4% during the 3rd quarter. Mutual of America Capital Management LLC now owns 45,900 shares of the company’s stock worth $4,333,000 after purchasing an additional 45,707 shares during the last quarter. Finally, Columbia Partners L.L.C. Investment Management purchased a new stake in Healthequity during the 3rd quarter worth approximately $687,000. 93.01% of the stock is owned by hedge funds and other institutional investors.
HQY has been the topic of several research analyst reports. BidaskClub raised shares of Healthequity from a “buy” rating to a “strong-buy” rating in a research report on Thursday, November 1st. SunTrust Banks downgraded shares of Healthequity from a “buy” rating to a “hold” rating and dropped their target price for the stock from $105.00 to $90.00 in a research report on Thursday. Bank of America downgraded shares of Healthequity from a “buy” rating to a “neutral” rating and boosted their target price for the stock from $84.00 to $105.00 in a research report on Thursday, September 6th. They noted that the move was a valuation call. Zacks Investment Research downgraded shares of Healthequity from a “buy” rating to a “hold” rating in a research report on Tuesday, November 20th. Finally, Wells Fargo & Co boosted their target price on shares of Healthequity from $84.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 5th. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $90.92.
HQY stock opened at $68.38 on Friday. The firm has a market capitalization of $4.59 billion, a PE ratio of 126.63, a price-to-earnings-growth ratio of 2.72 and a beta of 1.37. Healthequity Inc has a 12 month low of $42.92 and a 12 month high of $101.58.
Healthequity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, December 4th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.20 by $0.02. The business had revenue of $70.50 million for the quarter, compared to the consensus estimate of $69.60 million. Healthequity had a net margin of 24.52% and a return on equity of 12.42%. The business’s revenue for the quarter was up 24.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.17 EPS. As a group, sell-side analysts predict that Healthequity Inc will post 0.87 earnings per share for the current fiscal year.
In other news, VP Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction on Monday, October 22nd. The shares were sold at an average price of $87.01, for a total value of $348,040.00. Following the sale, the vice president now directly owns 92,500 shares of the company’s stock, valued at approximately $8,048,425. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders sold a total of 12,000 shares of company stock worth $1,027,400 over the last ninety days. Insiders own 4.00% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This story was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.americanbankingnews.com/2018/12/08/healthequity-inc-hqy-position-lowered-by-king-luther-capital-management-corp.html.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Article: Why is the LIBOR significant?
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.